Remote Device Interrogation In The Emergency Department
NCT ID: NCT01871090
Last Updated: 2019-02-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
99 participants
INTERVENTIONAL
2013-09-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Expected duration of the study is 6 months. Once enrolled the patient will participate in the study for the duration of the Emergency Department stay, until discharged or admitted to the hospital.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Interrogation in Rural Emergency Departments
NCT02421549
Clinical Evaluation Of Remote Monitoring With Direct Alerts To Reduce Time From Event To Clinical Decision
NCT01090349
SJM MRI Diagnostic Imaging Registry (IDE)
NCT02807948
REmote MOnitoring of paTiEnts witH pacEmaker or implAntable cardioverteR defibrillaTor
NCT06173089
Safety of Magnetic Resonance Imaging in Non-MRI Conditional Pacemakers and ICD Devices
NCT02906189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interrogation with unpaired remote transmitter
Interrogation with an unpaired remote monitoring transmitter for devices that are compatible.
Unpaired remote monitoring transmitter
Unpaired remote monitoring transmitter
Interrogation with programmer
Interrogation with programmer according to usual standard of care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Unpaired remote monitoring transmitter
Unpaired remote monitoring transmitter
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Are 18 years of age or older, or of legal age to give informed consent specific to state law.
3. Are willing and able to provide informed consent for study participation.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Girsky, MD
Role: PRINCIPAL_INVESTIGATOR
Los Angeles Biomedical Research Institute at Harbor - UCLA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Genesis Healthcare System
Zanesville, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
60047158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.